Sarcoidosis Health Care Disparities and Clinical Research Challenges
Sarcoidosis Health Care Disparities and Clinical Research Challenges
批准号:
8836634
负责人:
ELLIOTT D CROUSER
金额:
$1.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-10 至 2015-08-31
关键词:
AddressAfricaAfrican AmericanAmericasAreaAwardBasic ScienceBehaviorBiological MarkersCaringClinicalClinical ResearchClinical TrialsClinical Trials DesignCollaborationsCommunitiesConsensusDetectionDevelopmentDiagnosticDisadvantagedDiseaseDisease ProgressionDisease modelEnvironmentEpidemiologyEuropeEventFacultyFeesFosteringGeneticGenomicsGrantGranulomatousHealthHealth ProfessionalHealth Services AccessibilityHealthcareHispanicsImmigrantIndiaInstitutionKnowledgeLifeLungMissionModelingNational Heart, Lung, and Blood InstituteNatureOhioOrganismParticipantPathogenesisPatientsPhenotypePhysiciansPopulationPostdoctoral FellowPrevalencePublic HealthPulmonary SarcoidosisQuality of lifeRare DiseasesRegistriesResearchResearch DesignResearch PersonnelResourcesSarcoidosisScientistSocietiesStagingStudentsTrainingTranslatingTranslational ResearchTravelUnderrepresented MinorityUnderserved PopulationUnited States National Institutes of HealthUniversitiesWomanbasecareer developmentcostdisabilitygraduate studentimaging modalityimprovedmeetingsnovelpatient advocacy groupprogramspublic health relevancesymposiumtool
中文摘要
描述(由申请人提供):美洲结节病和其他肉芽肿性疾病协会(AASOG)是一个由医生和内科科学家领导的组织,致力于改善结节病患者的发病机制和治疗,结节病是一种鲜为人知的疾病,通常困扰代表不足的少数族裔。AASOG是世界结节病和其他肉芽肿性疾病协会(WASOG)的子公司,WASOG总部设在欧洲,成立于1987年。AASOG此前主办了5次年度全国会议,第6届年会与之前的AASOG活动(以及与结节病有关的其他论坛)的不同之处在于,该计划将有一个特定的主题,会议标题:结节病医疗差距和临床研究挑战。在这方面,大多数被邀请的参与者是代表不足的少数族裔,许多参与者以前没有参加过AASOG赞助的活动,是初级教员或实习生。对任职人数不足的少数群体的关注超出了受邀与会者的范围,因为较低的注册费将使代表不足的少数群体很容易参加这次会议。通过免除注册费和根据研究报告的质量向5000名学生提供旅行奖励,将进一步鼓励学员参加会议。此外,高度互动的科学环境和与知名研究科学家的接触将有助于他们的职业发展。因此,本次会议将鼓励和促进致力于推进结节病研究和治疗的新科学家的发展。因此,2014年AASOG会议将支持与国家卫生和公共卫生研究所的科学任务直接相关的各种活动。
英文摘要
DESCRIPTION (provided by applicant): The Americas Association of Sarcoidosis and Other Granulomatous Disorders (AASOG) is a physician and physician-scientist led organization that is devoted to improving the pathogenesis and treatment of patients with sarcoidosis, a poorly understood disease that commonly afflicts underrepresented minorities. AASOG is a subsidiary of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG), which is based in Europe and was founded in 1987. AASOG has previously sponsored 5 annual national meetings, and the 6th annual meeting represents a departure from the previous AASOG events (and other forums relating to sarcoidosis) in that the program will have a specific theme, as reflected by the meeting title: Sarcoidosis Health Care Disparities and Clinical Research Challenges. In this context, a majority of the invited participants are underrepresented minorities, and many of the attendees have not previously participated in AASOG sponsored activities and are junior faculty or trainees. The focus on underrepresented minorities extends beyond the invited participants in that the low registration fees will make this meeting highly accessible to underrepresented minorities. Trainee participation in the meeting will be further encouraged by waiving registration fees and providing travel awards to 5 students based upon the quality of their research presentations. Furthermore, the highly interactive scientific environment and engagement with well-established research scientists will be conducive to their career development. This meeting will thereby encourage and promote the development of new scientists dedicated to the advancement of sarcoidosis research and treatment. Thus, the 2014 AASOG meeting will support a variety of activities that are directly relevant to the scientific missions of the National Institutes of Health and public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Renin-Angiotensin-Aldosterone System during sarcoidosis granuloma formation
-
批准号:10591934
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2022
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
-
批准号:10657726
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2022
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
-
批准号:10406027
-
项目类别:
-
资助金额:$57.66万
-
财政年份:2022
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Circulating Exosome microRNA as Markers of Severe Sarcoidosis Phenotypes
-
批准号:9434044
-
项目类别:
-
资助金额:$12.26万
-
财政年份:2017
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study
-
批准号:8915741
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2014
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study
-
批准号:8753389
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2014
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Dendritic Cell Activation by Mitochondrial Transcription Factor A
-
批准号:7707655
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2009
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Dendritic Cell Activation by Mitochondrial Transcription Factor A
-
批准号:7897735
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Induction of Inflammation by Mitochondrial Proteins
-
批准号:7086145
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2005
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Induction of Inflammation by Mitochondrial Proteins
-
批准号:6965294
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2005
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Stromal Gene Expression During Pulmonary Sarcoidosis
-
批准号:6815516
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2004
-
负责人:ELLIOTT D CROUSER
-
依托单位:
Stromal Gene Expression During Pulmonary Sarcoidosis
-
批准号:6920007
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2004
-
负责人:ELLIOTT D CROUSER
-
依托单位:
MITOCHONDRIAL CYTOCHROME C RELEASE VIA MEMBRANE PORES
-
批准号:6091395
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2000
-
负责人:ELLIOTT D CROUSER
-
依托单位:
MITOCHONDRIAL CYTOCHROME C RELEASE VIA MEMBRANE PORES
-
批准号:6724898
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2000
-
负责人:ELLIOTT D CROUSER
-
依托单位:
MITOCHONDRIAL CYTOCHROME C RELEASE VIA MEMBRANE PORES
-
批准号:6536638
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2000
-
负责人:ELLIOTT D CROUSER
-
依托单位:
MITOCHONDRIAL CYTOCHROME C RELEASE VIA MEMBRANE PORES
-
批准号:6388655
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2000
-
负责人:ELLIOTT D CROUSER
-
依托单位:
MITOCHONDRIAL CYTOCHROME C RELEASE VIA MEMBRANE PORES
-
批准号:6638154
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2000
-
负责人:ELLIOTT D CROUSER
-
依托单位:
海外基金